Gyre Therapeutics
GYRE
GYRE
56 hedge funds and large institutions have $236M invested in Gyre Therapeutics in 2018 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 18 increasing their positions, 2 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
60% more funds holding
Funds holding: 35 → 56 (+21)
3.61% more ownership
Funds ownership: 6.66% → 10.27% (+3.6%)
55% less call options, than puts
Call options by funds: $2.29M | Put options by funds: $5.15M
Holders
56
Holding in Top 10
5
Calls
$2.29M
Puts
$5.15M
Top Buyers
| 1 | +$24.5M | |
| 2 | +$21.4M | |
| 3 | +$18.2M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$16.1M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$13.3M |
Top Sellers
| 1 | -$818K | |
| 2 | -$611K | |
| 3 | -$585K | |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$529K |
| 5 |
KM
Kalos Management
Alpharetta,
Georgia
|
-$222K |